In recent years, researchers have begun to report once more on the many medical uses of psychedelics. Far from being new discoveries, many of these findings are replicating much of what was already becoming known about these substances in the first wave of psychedelic research that spanned the 40s, 50s, and 60s. Treating post-traumatic stress disorder, substance abuse, and end-of-life anxiety in terminal patients are amazing and much-needed applications, and they’re also the tip of the iceberg of what’s possible.
For one extremely interesting example, here’s a quote from a passage of Stanislav Grof’s “LSD Psychotherapy” where he describes the various applications of psychedelic therapy:
Sexual experiences and behavior can be deeply influenced by the LSD process. The intensity, depth and completeness of the sexual orgasm and the ease with which it occurs seems to be closely related to the process of letting go of psychological defenses. Many problems in this area can be traced back to unconscious confusion between the pattern of genital orgasm and that of the total physical release that characterizes the orgasm of birth. As LSD subjects learn to let go in the death-rebirth process, their orgasmic ability increases considerably; this improvement of sexual experiences can be observed in both males and females. In those individuals who did not have any major psychopathological symptoms prior to the LSD session, the same effect can usually be observed after one or several high-dose psychedelic experiences. Sexual neuroses, such as frigidity, vaginal spasms (vaginism), genital pain during intercourse, impotence and premature ejaculation frequently respond well to LSD psychotherapy; however, effective treatment of these disorders usually requires serial administration of the drug and experiential confrontation of the roots of these disorders on the perinatal level.